Tag: direct-to-consumer

direct-to-consumer

Regulatory/FDA

OPDP to Study Risk/Benefit Tradeoff Decisions Made by Consumers, Physicians

OPDP to Study Risk/Benefit Tradeoff Decisions Made by Consumers, Physicians

May 31, 2022 – Understanding the tradeoffs among desirable and undesirable drug product characteristics that consumers and their treating physicians make “will provide valuable insight into the relevance and impact of various product attributes and promotional claims on informed choices and treatment decisions,” according to the Food and Drug Administration’s Office of Prescription Drug Promotion […]

Read more